We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

149 hedge funds and large institutions have $1.04B invested in Ocular Therapeutix in 2020 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

315% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 13

246% more capital invested

Capital invested by funds: $301M → $1.04B (+$742M)

147% more call options, than puts

Call options by funds: $12.3M | Put options by funds: $4.96M

100% more funds holding in top 10

Funds holding in top 10: 5 → 10 (+5)

38% more funds holding

Funds holding: 108 → 149 (+41)

37% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 35

3.8% more ownership

Funds ownership: 63.18% → 66.98% (+3.8%)

Holders
149
Holders Change
+41
Holders Change %
+37.96%
% of All Funds
2.64%
Holding in Top 10
10
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+100%
% of All Funds
0.18%
New
54
Increased
48
Reduced
35
Closed
13
Calls
$12.3M
Puts
$4.96M
Net Calls
+$7.31M
Net Calls Change
+$7.48M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$21.2M
2
EA
Emerald Advisers
Pennsylvania
+$17.7M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$16.7M
4
Victory Capital Management
Victory Capital Management
Texas
+$16.1M
5
GPP
Great Point Partners
Connecticut
+$12.7M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$29.4M
2
IC
Ikarian Capital
Texas
-$15.3M
3
VVM
Versant Venture Management
California
-$11.1M
4
ECM
Endurant Capital Management
California
-$8.12M
5
DAM
Deltec Asset Management
New York
-$4.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
126
Macquarie Group
Australia
$36K +$25.9K +1,746 New
DWA
127
Dorsey Wright & Associates
California
$34K +$6.12K +412 +33%
PCM
128
Penserra Capital Management
California
$33K +$24.4K +1,640 New
CWA
129
Clearview Wealth Advisors
Oregon
$32K +$23.2K +1,561 New
IA
130
IFP Advisors
Florida
$31K +$22.3K +1,500 New
ED
131
Exane Derivatives
France
$31K +$22.2K +1,496 New
FC
132
FORA Capital
Florida
$29K -$133K -8,955 -86%
Carson Wealth (CWM LLC)
133
Carson Wealth (CWM LLC)
Nebraska
$28K – – –
CA
134
Centerpoint Advisors
Massachusetts
$26K – – –
LGA
135
Lebenthal Global Advisors
New York
$17K +$12.3K +830 New
Osaic Holdings
136
Osaic Holdings
Arizona
$12K -$8.15K -549 -48%
Russell Investments Group
137
Russell Investments Group
United Kingdom
$11K +$8.35K +562 New
CAPTRUST Financial Advisors
138
CAPTRUST Financial Advisors
North Carolina
$10K – – –
HWM
139
HighMark Wealth Management
Minnesota
$8K -$29.7K -2,000 -83%
PFGIA
140
Patriot Financial Group Insurance Agency
Massachusetts
$8K – – –
PAM
141
Panagora Asset Management
Massachusetts
$7K -$10.7K -721 -67%
GRP
142
Global Retirement Partners
California
$5K -$1.11K -75 -25%
ASN
143
Advisory Services Network
Georgia
$5K – – –
SFS
144
Sowell Financial Services
Arkansas
$4K – – –
S
145
SignatureFD
Georgia
$3K – – –
Daiwa Securities Group
146
Daiwa Securities Group
Japan
$3K +$1.99K +134 New
ADIM
147
Alpha DNA Investment Management
Maryland
$1K +$1.22K +82 New
AIG
148
American International Group
New York
$825 +$55K +3,702 +10%
Millennium Management
149
Millennium Management
New York
– -$1.44K -189,007 Closed
DTL
150
Dynamic Technology Lab
Singapore
– -$304K -39,974 Closed
3 4 5
6
7

OCUL Hedge Fund Activity: Q4 2020 in Review

149 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q4 2020, worth a combined $1.04B — up 246% from $301M a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new OCUL positions and 13 closed out — a net gain of 41 holders — while 48 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock, adding an estimated $21.2M. The largest seller was RA Capital Management, cutting an estimated $29.4M.

  • 149 institutional investors held Ocular Therapeutix (OCUL) as of Q4 2020, up from 108 in Q3 2020.
  • Funds reported $1.04B of Ocular Therapeutix stock for Q4 2020, up 246% quarter-over-quarter.
  • 54 funds opened new Ocular Therapeutix positions in Q4 2020 and 13 closed out, a net change of +41 holders.
  • The largest Ocular Therapeutix buyer in Q4 2020 was BlackRock, an estimated $21.2M added.
  • The largest Ocular Therapeutix seller in Q4 2020 was RA Capital Management, an estimated $29.4M sold.

Based on aggregated 13F filings for Q4 2020.